Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
Complaint alleged Besins Hormone Academy webpages were disguised promotion. Panel found it was clearly a Besins HCP site with PI link and…
NHS Health Board HCPs alleged an Ethypharm representative made unannounced visits and shared factually incorrect information about blocked prefilled syringes. Panel ruled…
GSK was complained about after a senior leader mentioned “Arexvy” once in a LinkedIn video tied to FY2023 results. Panel found the…
Ipsen admitted an employee in a promotional role in Northern Ireland had no verified ABPI representative exam on file. PMCPA ruled breaches…
PMCPA ruled GSK’s Zejula “PRIMA AE management” webpage misleading for implying AEs could be managed by dose interruption/modification without highlighting when SmPC…
PMCPA recorded a complaint about a GSK webpage. The case was concluded as outwith the scope of the ABPI Code of Practice,…
Complaint about a regional e-consent proposal and alleged proactive sharing of preprint data/off-label risk. Panel found the complainant provided limited evidence and…
Acepiro (acetylcysteine) banner ad on a learned society homepage lacked the required adverse event reporting statement within the ad itself. Linking to…
Two UK-based GSK employees ‘liked’ a LinkedIn post about US FDA approval for Jemperli + chemotherapy. Panel ruled this brought the post…
Three UK AstraZeneca employees ‘liked’ a third‑party LinkedIn post about pre-clinical osimertinib resistance reversal. PMCPA said the likes disseminated favourable content to…
PMCPA case AUTH/3870/1/24 against AstraZeneca concerned allegations about clinical trial material. The matter was found outwith the scope of the ABPI Code;…
GSK’s GSK.pro page claimed Trelegy had greater exacerbation reduction vs “another” triple therapy without naming the comparator. Panel found the headline implied…
PMCPA found GSK’s “Trevor trusts Trelegy” claim on an HCP website was ambiguous, misleading and not capable of substantiation. Related video phrase…
PMCPA case AUTH/3870/1/24 against AstraZeneca concerned allegations about clinical trial material. The matter was found outwith the scope of the ABPI Code:…
Senior UK-based AstraZeneca employees ‘liked’ LinkedIn posts about Imfinzi combinations and trial results. The Panel found promotion to the public, pre-authorisation promotion,…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
